Use of GLP-1 compound for treatment of critically ill patients
First Claim
Patent Images
1. A method for treating a patient having critical illness polyneuropathy (CIPNP), said method comprising administering to said patient a therapeutically effective amount of a GLP-1 compound, wherein the GLP-1 compound is Arg34, Lys26(Nε
- -(γ
-Glu(Nα
-hexadecanoyl)))-GLP-1(7-37).
0 Assignments
0 Petitions
Accused Products
Abstract
Use of medicament for life saving treatment of critically ill patients and method of treatment. The medicament comprises a GLP-1 compound which effectively controls the blood glucose level.
64 Citations
28 Claims
-
1. A method for treating a patient having critical illness polyneuropathy (CIPNP), said method comprising administering to said patient a therapeutically effective amount of a GLP-1 compound, wherein the GLP-1 compound is Arg34, Lys26(Nε
- -(γ
-Glu(Nα
-hexadecanoyl)))-GLP-1(7-37). - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28)
- -(γ
Specification